approval
saveMEPRON (ATOVAQUONE) — FDA approval
community read0 votes
Sponsor: GLAXOSMITHKLINE LLC. Form: SUSPENSION. Route: ORAL
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalMar 23, 2026 · 194d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalJul 18, 2019 · 2634d ago
- approvalMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalFeb 22, 2019 · 2780d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalFeb 22, 2019 · 2780d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalOct 15, 2017 · 3275d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalJun 4, 2015 · 4139d ago
- approvalMEPRON (ATOVAQUONE) — FDA approvalMar 1, 2013 · 4964d ago
- approvalMALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalFeb 27, 2013 · 4966d ago
same company · ±60 days · 6
- approvalmomelotinib dihydrochloride: OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA approvalMar 18, 2026
- approvalmomelotinib dihydrochloride: OJJAARA (MOMELOTINIB DIHYDROCHLORIDE) — FDA approvalMar 18, 2026
- approvallinerixibat: LYNAVOY (LINERIXIBAT) — FDA approvalMar 17, 2026
- approvalatovaquone: MALARONE PEDIATRIC (ATOVAQUONE) — FDA approvalMar 23, 2026
- approvalniraparib: ZEJULA (NIRAPARIB TOSYLATE) — FDA approvalMar 27, 2026
- approvalLEUCOVORIN CALCIUM: WELLCOVORIN (LEUCOVORIN CALCIUM) — FDA approvalMar 9, 2026
comments(0)
5-min edit window · permanent after that